In September, ECHA working groups will meet to evaluate the combination Poly(oxy-1,2-ethanediyl), α-[2-(dide- cylmethylammonium)ethyl]- .omega.- hydroxy-, propanoate (salt) (Bardap 26), CAS 94667-33-1, PT 2 and 4
Between the 5th and 16th of September the Working Groups will discuss the approval of Poly(oxy-1,2-ethanediyl), α-[2-(dide-cylmethylammonio)ethyl]- .omega.- hydroxy-, propanoate (salt) (Bardap 26) [CAS 94667-33-1; EC 619-057-3] for PT 2 and 4.
The Working Groups carry out scientific and technical peer reviews about:
- analytical Methods and Physico-chemical Properties;
- human Health Risk Assessment;
- environmental Risk Assessment.
Their considerations will be assessed by the BPC (Biocidal Product Committee) that will discuss between the 21st and 25th of November 2022 and will prepare its final opinion about the combination of active substances-PTs taken into account. The final decisions are taken by the European Commission which will publish the implementing regulation in the official journal of the European Union.
Usually, the date of approval of the active substance-PT combination is set by the Commission after 18 months from the publication in the journal; therefore, TEAM mastery suggests to all companies having products based on Bardap 26 for PT 2 and 4 applications to start managing the regulatory authorization process. This will allow companies to organize with due diligence laboratory tests, prepare the dossier, conduct the pre-submission meeting with the designated evaluating Competent Authority and be compliant with the national legislation to benefit from the transitional measures according to BPR regulation, ahead of time.
Please, do not hesitate to contact TEAM mastery, in the person of Stefano Tortelli, head of the Biocides department, at email@example.com, to define the best authorisation strategy or ask for more information.